Breast cancer grades | Top Doctors

As a breast oncologist, I believe it’s essential to provide a clear understanding of the grades of breast cancer to my patients. Breast cancer grade refers to how abnormal the cancer cells look under a microscope and provides important information about the aggressiveness of the cancer and how likely it is to grow and spread. The grade is determined by examining the cancer cells' appearance and how different they are from normal, healthy breast cells.

How is breast cancer graded?

Breast cancer is commonly graded on a scale from 1 to 3, with the following classifications:

Grade 1 (Low Grade)

Grade 1 breast cancer is characterised by cancer cells that closely resemble normal, healthy breast cells. These cells tend to grow and spread at a slower rate compared to higher-grade cancers. Grade 1 tumours are often referred to as well-differentiated, indicating that the cancer cells maintain some of the features of healthy breast tissue. This lower grade often correlates with a better prognosis, and the cancer is generally considered less aggressive.

Grade 2 (Intermediate Grade)

Grade 2 breast cancer consists of cancer cells that are somewhat abnormal in appearance and may be growing and dividing at a moderate rate. This grade is termed moderately differentiated, reflecting that the cancer cells show some features of healthy breast tissue but also exhibit more abnormal characteristics. The behaviour of Grade 2 tumours falls between the slower-growing Grade 1 tumours and the faster-growing Grade 3 tumours.

Grade 3 (High Grade)

Grade 3 breast cancer is characterised by cancer cells that appear highly abnormal and tend to grow and spread more rapidly than lower-grade cancers. These cells are poorly differentiated, meaning they have lost many of the features of normal breast cells and are more aggressive in their behaviour. Grade 3 tumours are associated with a less favourable prognosis due to their higher potential for growth and metastasis.

What part does determining the grade play in diagnosis of breast cancer?

Determining the grade of breast cancer is an important part of the diagnostic process, as it helps guide treatment decisions and provides valuable information about the likely behaviour of the cancer. In addition to the grade, other factors, such as the tumour's size, hormone receptor status, HER2 status, and lymph node involvement, are considered when developing a personalised treatment plan for each patient.

As a breast oncologist, I collaborate closely with pathologists, radiologists, and other members of the multidisciplinary team to ensure an accurate diagnosis and comprehensive evaluation of each patient's breast cancer. By incorporating the grade of the cancer with other clinical and biological factors, I can tailor treatment recommendations to address the unique characteristics of the tumour and the individual patient's needs.

What is your aim when it comes to ensuring patients are fully informed about breast cancer grades?

My goal is to empower my patients with knowledge and understanding, enabling them to participate actively in decisions about their care. I place great emphasis on clear communication, providing detailed explanations of the significance of the cancer grade and its implications for the treatment approach. I encourage my patients to ask questions and express their concerns, as I am keen to work collaboratively with my patients to develop a treatment plan that aligns with their goals and supports their well-being throughout their breast cancer journey.

In the rapidly evolving landscape of breast cancer treatment, my commitment as a breast oncologist is to stay up to date with the latest research and advances in my field. This allows me to offer my patients access to cutting-edge therapies and clinical trials, ensuring that they receive the most innovative and effective care available.

Ultimately, I see my role as a breast oncologist, is to provide expert guidance, compassionate support, and personalised care to each patient, incorporating the information provided by the grade of the breast cancer to deliver tailored treatment strategies.